Cargando…

Liver injury after mRNA-based SARS-CoV-2 vaccination in a liver transplant recipient

Detalles Bibliográficos
Autor principal:	Dumortier, Jérôme
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Masson SAS. 2022
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8214934/ https://www.ncbi.nlm.nih.gov/pubmed/34146727 http://dx.doi.org/10.1016/j.clinre.2021.101743

Ejemplares similares

Influenza and SARS-CoV-2 vaccinations adherence after liver transplantation during the second year of the COVID-19 pandemic (results of a patients’ survey)
por: Dumortier, Jérôme, et al.
Publicado: (2022)

Antibody Kinetics and Durability in SARS-CoV-2 mRNA Vaccinated Solid Organ Transplant Recipients
por: Boyarsky, Brian J., et al.
Publicado: (2021)

A fourth SARS-CoV-2 mRNA vaccine in strictly seronegative kidney transplant recipients
por: Masset, Christophe, et al.
Publicado: (2022)

Immune Response Post–SARS-CoV-2 mRNA Vaccination in Kidney Transplant Recipients Receiving Belatacept
por: Noble, Johan, et al.
Publicado: (2021)

SARS-CoV-2 infection in liver transplant recipients: A complex relationship
por: Alberca, Ricardo Wesley, et al.
Publicado: (2021)

Weak anti–SARS-CoV-2 antibody response after the first injection of an mRNA COVID-19 vaccine in kidney transplant recipients
por: Benotmane, Ilies, et al.
Publicado: (2021)

Low immunization rates among kidney transplant recipients who received 2 doses of the mRNA-1273 SARS-CoV-2 vaccine
por: Benotmane, Ilies, et al.
Publicado: (2021)

Immunogenicity of SARS‐CoV‐2 mRNA vaccine in solid organ transplant recipients
por: Holden, Inge K., et al.
Publicado: (2021)

Co-infection with SARS-CoV-2 and Pneumocystis jirovecii in liver transplant recipients: A double whammy
por: Kronsten, Victoria Tatiana, et al.
Publicado: (2021)

Boosting compromised SARS-CoV-2-specific immunity with mRNA vaccination in liver transplant recipients
por: Luxenburger, Hendrik, et al.
Publicado: (2023)

Mycophenolate mofetil decreases humoral responses to three doses of SARS‐CoV‐2 vaccine in liver transplant recipients
por: Meunier, Lucy, et al.
Publicado: (2022)

Humoral Response After 6 or More Successive Doses of SARS-CoV-2 mRNA Vaccines in Kidney Transplant Recipients—Should We Keep Vaccinating?
por: Åsberg, Anders, et al.
Publicado: (2023)

Effectiveness of SARS-CoV-2 vaccination in liver transplanted patients: The debate is open!
por: Guarino, Maria, et al.
Publicado: (2022)

Antibody and T-cell response to a third dose of SARS-CoV-2 mRNA BNT162b2 vaccine in kidney transplant recipients
por: Bertrand, Dominique, et al.
Publicado: (2021)

Clinical update on the efficacy of anti-SARS-CoV-2 mRNA vaccines in patients on the waiting list for liver transplantation and in liver transplant recipients
por: Toniutto, Pierluigi, et al.
Publicado: (2021)

Antibody response to SARS-CoV-2 mRNA BNT162b2 vaccine in kidney transplant recipients and in-centre and satellite centre haemodialysis patients
por: Bertrand, Dominique, et al.
Publicado: (2021)

Reply to: “Effectiveness of SARS-CoV-2 vaccination in liver transplanted patients: The debate is open!”
por: Rabinowich, Liane, et al.
Publicado: (2022)

SARS-CoV-2 breakthrough infections in vaccinated kidney transplant recipients: an issue of concern
por: Wijtvliet, Veerle, et al.
Publicado: (2021)

SARS-CoV-2 vaccination–associated collapsing glomerulopathy in a kidney transplant recipient
por: Jefferis, Julia, et al.
Publicado: (2022)

Liver injury following SARS-CoV-2 vaccination: A multicenter case series
por: Shroff, Hersh, et al.
Publicado: (2022)

Cases of severe acute liver injury following inactivated SARS-CoV-2 vaccination.
por: Kulkarni, Anand V., et al.
Publicado: (2022)

Persistence of SARS-CoV-2 antibodies in kidney transplant recipients
por: Benotmane, Ilies, et al.
Publicado: (2021)

Reduced humoral response to mRNA SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients without prior exposure to the virus: No cause for alarm
por: Mossad, Sherif Beniameen
Publicado: (2021)

SARS CoV2 mRNA vaccines: Prolonged dosing intervals and anti-SARS-CoV-2 immunity status
por: Ghazvini, Kiarash, et al.
Publicado: (2022)

SARS CoV2 mRNA vaccines: Prolonged dosing intervals and anti-SARS-CoV-2 immunity status
por: Ghazvini, Kiarash, et al.
Publicado: (2022)

Real-world Impact of 2-dose SARS-CoV-2 Vaccination in Kidney Transplant Recipients
por: McEvoy, Caitríona M., et al.
Publicado: (2022)

SARS-CoV-2 mRNA vaccination, prostate cancer and steroids: Correspondence
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Influenza vaccination adherence after liver transplantation: A collateral benefit of the COVID-19 pandemic (results of a patients’ survey)
por: Dumortier, Jérôme, et al.
Publicado: (2022)

Antibody response after a third dose of the mRNA-1273 SARS-CoV-2 vaccine in liver transplant recipients
por: Herrán, Aitor Odriozola, et al.
Publicado: (2022)

Humoral and Cellular Immune Response After Third and Fourth SARS-CoV-2 mRNA Vaccination in Liver Transplant Recipients
por: Harberts, Aenne, et al.
Publicado: (2022)

Cellular and humoral immune response after mRNA-1273 SARS-CoV-2 vaccine in liver and heart transplant recipients
por: Herrera, Sabina, et al.
Publicado: (2021)

A Vector-Based Vaccine Dose After 3 Doses of mRNA-Based COVID-19 Vaccination Does Not Substantially Improve Humoral SARS-CoV-2 Immunity in Renal Transplant Recipients
por: Roch, Toralf, et al.
Publicado: (2022)

Parsonage Turner Syndrome Following Vaccination With mRNA-1273 SARS-CoV-2 Vaccine
por: Bernheimer, James H., et al.
Publicado: (2022)

Small-Fiber Neuropathy After Vaccination With mRNA-1273 SARS-CoV-2 Vaccine
por: Bernheimer, James H., et al.
Publicado: (2023)

Immune-mediated liver injury represented as overlap syndrome after SARS-CoV-2 vaccination
por: Lee, Soon Kyu, et al.
Publicado: (2022)

Humoral and T-cell response to SARS-CoV-2 mRNA BNT162b2 vaccination in a cohort of kidney transplant recipients and their cohabitant living kidney donor partners
por: La Milia, Vincenzo, et al.
Publicado: (2022)

SARS-CoV-2 antibody response eight months after vaccination with mRNA vaccines. Influence of prior SARS-CoV-2 exposure
por: García-Cruces-Méndez, Jesús Fernando, et al.
Publicado: (2022)

Humoral response to a fourth dose of mRNA vaccine in kidney transplant recipient responders to three doses of mRNA vaccine
por: de Nattes, Tristan, et al.
Publicado: (2022)

Efficacy and safety of SARS-CoV-2 vaccination in liver transplant recipients
por: Meunier, Lucy, et al.
Publicado: (2022)

Improved immunogenicity against SARS-CoV-2 in a solid-organ transplant recipient by switching vaccines
por: al Jalali, Valentin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_kokm489pvkf9a725i4cl9eaurq